Publicaciones
-
Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ and Hulleman E.
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
MOLECULAR CANCER THERAPEUTICS . 15(9): 2166-2174. Nº de citas: 51
-
Zacharoulis S, Morales-La Madrid A, Bandopadhayay P, Chi SN, Manley P, Ullrich NN, Marcus K, Goumnerova L, Scott RM, Proctor M, Young-Poussaint T, De Girolami U and Kieran MW.
Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 38(6): 479-485. Nº de citas: 11
-
Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
PLoS One . 11(7): . Nº de citas: 21
-
Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein
Oncotarget . 7(29): 46283-46300. Nº de citas: 12
-
Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M and Moreno L.
Landscape of early clinical trials for childhood and adolescence cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY . 18(7): 708-713. Nº de citas: 6
-
Veldhuijzen van Zanten, S.E.M., Cruz-Martínez O, Kaspers, G.J.L., Hargrave, D.R., van Vuurden, D.G. and Siope Dipg Network.
State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature.
JOURNAL OF NEURO-ONCOLOGY . 128(3): 387-394. Nº de citas: 20
-
Millan NC, Poveda MJ, Cruz-Martínez O and Mora J.
Safety of bevacizumab in patients younger than 4 years of age
CLINICAL & TRANSLATIONAL ONCOLOGY . 18(5): 464-468. Nº de citas: 12
-
Paco-Mercader S, Hummel M, Plá V, Sumoy L and Aguado F.
Cyclic AMP signaling restricts activation and promotes maturation and antioxidant defenses in astrocytes
BMC Genomics . 17: 304-304. Nº de citas: 37
-
Krauel L, Fenollosa F, Riaza L, Pérez M, Tarrado X, Morales-La Madrid A, Gomà J and Mora J.
Use of 3D Prototypes for Complex Surgical Oncologic Cases
WORLD JOURNAL OF SURGERY . 40(4): 889-894. Nº de citas: 44
-
Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz-Martínez O, Kaspers GJ, van Vuurden DG, Hargrave DR and SIOPE DIPG Network.
Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Neuro-Oncology . 18(4): 582-588. Nº de citas: 20